Skip to main content
. 2020 Mar 25;122(10):1461–1466. doi: 10.1038/s41416-020-0785-y

Table 1.

Patients characteristics.

All Vx-001 Placebo
No of patients % No of patients % No of patients %
190 89 101
Sex
   Males 132 69.5 60 67.4 72 71.3
   Females 58 30.5 29 32.6 29 28.7
Age
   >65 years 99 52.1 45 50.6 54 53.5
   <65 years 91 47.9 44 49.4 47 46.5
Histology
   NSQ 114 60.0 55 61.8 59 58.4
   SQ 72 37.9 34 38.2 38 37,6
   Mixte 4 2.1 0 0.0 4 4,0
Response to previous treatment
   OR 88 46.3 36 40.4 52 51.5
   SD 102 53.7 53 59.6 49 48.5
ECOG
   0 75 39.5 33 37.1 42 41.6
   1 115 60.5 56 62.9 59 58.4
Smoking status
   Never 25 13.2 10 11.2 15 14.9
   Smokers 165 86.8 79 88.8 86 85.1
   Heavy smokers (>25 years) 128 67.4 62 69.7 66 65.3
   Light smokers (<25 years) 35 18.4 17 19.1 18 17.8
   Missing 2 1.1 0 0,0 2 2.0